Cargando…
Valproate-Induced Encephalopathy Presenting at Therapeutic Blood Concentrations: A Case Report and Literature Review
Patients presenting with hyperammonemic encephalopathy are likely to have hepatic encephalopathy. However, valproate (an anticonvulsant and mood stabilizer) can also cause hyperammonemic encephalopathy and belongs on the differential for patients taking it, especially if there are recent contributor...
Autores principales: | Pavar, Gautham, Xu, Nicole, Sawar, Kinan, Trivedi, Vichar, Levine, Diane L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908421/ https://www.ncbi.nlm.nih.gov/pubmed/36779151 http://dx.doi.org/10.7759/cureus.33559 |
Ejemplares similares
-
The Treatment of Insomnia Secondary to Generalized Anxiety Disorder: Evaluating Escitalopram Use With Concomitant High-Resolution, Relational, Resonance-Based, Electroencephalic Mirroring (HIRREM)
por: Sawar, Kinan, et al.
Publicado: (2023) -
A Case of Valproate-Induced Hyperammonemic Encephalopathy
por: Zafar, Faraaz, et al.
Publicado: (2020) -
Valproate-Associated Transaminitis and Rhabdomyolysis
por: Sharma, Anupam, et al.
Publicado: (2023) -
Wernicke’s Encephalopathy Presenting as Sensorineural Hearing Loss
por: Bryant, Benjamin S.H., et al.
Publicado: (2020) -
Social Determinants in Clinical Decision Making: A Case of Mistaken Hepatic Encephalopathy
por: Almujarkesh, Mohamad K, et al.
Publicado: (2023)